Capecitabine in combination with Oxaliplatin (XELOX) as a first-line therapy for advanced gastric cancer.

MLA

Park, Yeon Hee, et al. “Capecitabine in Combination with Oxaliplatin (XELOX) as a First-Line Therapy for Advanced Gastric Cancer.” Cancer Chemotherapy and Pharmacology, vol. 61, no. 4, Apr. 2008, pp. 623–29. EBSCOhost, https://doi.org/10.1007/s00280-007-0515-7.

APA

Park, Y. H., Lee, J.-L., Ryoo, B.-Y., Ryu, M.-H., Yang, S. H., Kim, B. S., Shin, D. B., Chang, H. M., Kim, T. W., Yuh, Y. J., & Kang, Y.-K. (2008). Capecitabine in combination with Oxaliplatin (XELOX) as a first-line therapy for advanced gastric cancer. Cancer Chemotherapy and Pharmacology, 61(4), 623–629. https://doi.org/10.1007/s00280-007-0515-7

Chicago

Park, Yeon Hee, Jae-Lyun Lee, Baek-Yeol Ryoo, Min-Hee Ryu, Sung Hyun Yang, Bong Seog Kim, Dong Bok Shin, et al. 2008. “Capecitabine in Combination with Oxaliplatin (XELOX) as a First-Line Therapy for Advanced Gastric Cancer.” Cancer Chemotherapy and Pharmacology 61 (4): 623–29. doi:10.1007/s00280-007-0515-7.